Back to Journals » Drug Design, Development and Therapy » Volume 9

Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer

Total article views   HTML views PDF downloads Totals
16,036 Dovepress* 14,848+ 1,615 16,463
PubMed Central* 1,188 326 1,514
Totals 16,036 1,941 17,977
*Since 3 October 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar